Company profile DRIO

DarioHealth Corp
DarioHealth Corp. (NASDAQ:DRIO) is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric multi-chronic condition digital therapeutics platform.
Quarter analysis & expected interest

There is not enough data for DarioHealth portal to provide analysis

Correlation between past revenue and DarioHealth portal search interest

There is not enough data for DarioHealth portal to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for DarioHealth portal to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for DarioHealth login to provide analysis

Correlation between past revenue and DarioHealth login search interest

There is not enough data for DarioHealth login to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for DarioHealth login to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for DarioHealth app to provide analysis

Correlation between past revenue and DarioHealth app search interest

There is not enough data for DarioHealth app to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for DarioHealth app to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for DarioHealth glucose monitor to provide analysis

Correlation between past revenue and DarioHealth glucose monitor search interest

There is not enough data for DarioHealth glucose monitor to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for DarioHealth glucose monitor to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for DarioHealth diabetes management to provide analysis

Correlation between past revenue and DarioHealth diabetes management search interest

There is not enough data for DarioHealth diabetes management to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for DarioHealth diabetes management to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 08:31:49.

After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0.
DarioHealth stock expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).

YearQ1Q2Q3Q4
2019108
68
-37.0% QoQ
52
-23.5% QoQ
76
46.2% QoQ
2020 79
-26.9% YoY 3.9% QoQ
69
1.5% YoY -12.7% QoQ
196
276.9% YoY 184.1% QoQ
66
-13.2% YoY -66.3% QoQ
2021 132
67.1% YoY 100.0% QoQ
224
224.6% YoY 69.7% QoQ
92
-53.1% YoY -58.9% QoQ
114
72.7% YoY 23.9% QoQ
2022 74
-43.9% YoY -35.1% QoQ
153
-31.7% YoY 106.8% QoQ
84
-8.7% YoY -45.1% QoQ
163
43.0% YoY 94.0% QoQ
2023 67
-9.5% YoY -58.9% QoQ
148
-3.3% YoY 120.9% QoQ
145
72.6% YoY -2.0% QoQ
172
5.5% YoY 18.6% QoQ
2024 0
-100.0% YoY -100.0% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and DarioHealth stock search interestLast update: February 09 2024 08:31:48.
Correlation coefficient between keyword and revenue is -0.5
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 08:31:49.

The average 5 years interest of DarioHealth stock was 8.74 per week.
The last year interest of DarioHealth stock compared to the last 5 years has changed by 6.52%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 59.15%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for DarioHealth news to provide analysis

Correlation between past revenue and DarioHealth news search interest

There is not enough data for DarioHealth news to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for DarioHealth news to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for DarioHealth products to provide analysis

Correlation between past revenue and DarioHealth products search interest

There is not enough data for DarioHealth products to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for DarioHealth products to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for DarioHealth services to provide analysis

Correlation between past revenue and DarioHealth services search interest

There is not enough data for DarioHealth services to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for DarioHealth services to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for DRIO
Earnings date: 2024-03-07 After close
Company name: DarioHealth Corp
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-10-06T07:30:00-04:00

PR Newswire
DarioHealth Announces Independent Aon Analysis that Supports Estimated 2.5%-7.2% In-Year Reduction in Total Healthcare Costs

2026-09-17T07:30:00-04:00

PR Newswire
Dario Wins Contract with One of New Jersey's Largest Health Plans Representing 1.5 Million Covered Lives

2026-08-19T15:45:44.745785481Z

Analyst Upgrades
Alliance Global Partners Initiates Coverage On DarioHealth with Buy Rating, Announces Price Target of $12

2026-08-12T15:17:12.475827042Z

Analyst Upgrades
TD Cowen Maintains Hold on DarioHealth, Lowers Price Target to $8

2026-08-11T08:14:00-04:00

Earnings Call Transcripts
Dario Health Second Quarter 2026 Results Call - DARIOHEALTH CORP

2026-08-11T06:30:00-04:00

PR Newswire
DarioHealth Reports Second Quarter 2026 Financial Results

2026-08-04T07:30:00-04:00

PR Newswire
Dario Expands Provider-Backed Cardiometabolic Platform with New Women's Health and Sleep Solutions Aligning with Client Demand

2026-08-03T06:30:00-04:00

PR Newswire
DarioHealth to Report Second Quarter 2026 Results on Tuesday, August 11, 2026

2026-07-30T07:30:00-04:00

PR Newswire
Dario Launches Integrated GLP-1 Program, Combining Its Digital Chronic Care Platform with Provider-Backed Clinical Care in a Single End-to-End Experience

2026-07-22T08:00:00-04:00

PR Newswire
Dario Announces Pricing of a $23.5 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

2026-07-16T07:30:00-04:00

PR Newswire
Fortune 50 Employer Awards Dario Contract to Deliver AI-Powered Cardiometabolic Care Platform

2026-07-13T07:30:00-04:00

PR Newswire
Dario Expects Proprietary AI Engine DarioIQ™ to Increase Recurring Revenue from Existing Customers by 10-15%

2026-07-06T07:30:00-04:00

PR Newswire
Dario Signs New Agreement with a Major Health Insurer in Arizona Representing Hundreds of Thousands of Lives Through Amwell Partnership

2026-07-02T07:30:00-04:00

PR Newswire
Top National Health Plan Extends Agreement for Mental Health and Expands Dario Partnership into Cardiometabolic Care, Demonstrating Successful Multi-Condition Growth Strategy

2026-06-30T07:30:00-04:00

PR Newswire
Dario Appoints Former Humana Chief Compliance Officer Sean O'Reilly to Advisory Board to Support Strategic Growth and Healthcare Partnerships